Different Biomarkers of Response to Treatment with Selective Jak-1 Inhibitors in Rheumatoid Arthritis

Different Biomarkers of Response to Treatment with Selective Jak-1 Inhibitors in Rheumatoid Arthritis

Background: Rheumatoid arthritis (RA) is a systemic autoimmune disease that causes progressive joint damage. The Janus kinase (JAK) inhibitors (JAK-I) represent a new therapeutic option for RA patients, blocking the intracellular JAK-STAT pathway. Today, no studies have been conducted to determine w...

ver descrição completa

Detalhes bibliográficos
Principais autores: Maurizio Benucci, Francesca Li Gobbi, Paola Fusi, Arianna Damiani, Edda Russo, Serena Guiducci, Mariangela Manfredi, Valentina Grossi, Maria Infantino, Amedeo Amedei
Formato: Artigo
Idioma:English
Publicado em: IMR Press 2023-08-01
coleção:Frontiers in Bioscience-Landmark
Assuntos:
rheumatoid arthritis
jak inhibitors
upadacitinib
filgotinib
biomarkers
Acesso em linha:https://www.imrpress.com/journal/FBL/28/8/10.31083/j.fbl2808176

Internet

https://www.imrpress.com/journal/FBL/28/8/10.31083/j.fbl2808176

Registros relacionados